Loading stock data…
Labcorp Holdings Inc. (LH)
$279.58+8.11 (+2.99%)
Market ClosedLast close Jun 29
Labcorp Holdings Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Labcorp Holdings Inc. in the Healthcare sector is trading at $279.58 with a market capitalization of $21.2B. Wall Street consensus targets $310.12 (17 analysts), implying a +10.9% move over the next 12 months. The stock is currently 5% below its 52-week high of $293.72, remaining 5.1% above its 200-day moving average. On fundamentals, Piotroski 8/9 indicates strong financial quality, Altman Z in the safe zone. The Whystock Score of 100/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +10.9% upside over 12 months
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $3.54B↑ | $3.52B↓ | $3.56B↑ | $3.53B↑ | $3.35B |
| Gross Profit | $1.01B↑ | $993.20M↓ | $1.03B↓ | $1.05B↑ | $948.00M |
| Operating Income | $387.20M↑ | $382.00M↓ | $403.20M↑ | $398.60M↑ | $332.40M |
| Net Income | $277.80M↑ | $164.70M↓ | $261.10M↑ | $237.90M↑ | $212.80M |
Peer Comparison
JNJUNHPFE
Fundamentals
Labcorp Holdings Inc. provides laboratory services. It operates through two segments, Diagnostics Laboratories and Biopharma Laboratory Services. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyro...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$21.23B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
22.93
Beta
Defensive asset. Lower volatility than the S&P 500.
0.88
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.77%
ROE
Average efficiency. Growth may require heavy reinvestment.
10.79%
Volume
Today's trading volume
661,094
Recent News
Omada Health, Inc. (OMDA) Stock Jumps 10.5%: Will It Continue to Soar?
Omada Health, Inc. (OMDA) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Why Labcorp (LH) Is Up 6.1% After FDA Approval, Medicare Coverage Of ColoSense At-Home Test
Earlier this week, Labcorp announced the nationwide availability of ColoSense, the first FDA-approved RNA-based at-home colorectal cancer screening test, now covered for eligible Medicare and Medicare Advantage patients and aligned with major U.S. screening guidelines. The test’s combination of RNA biomarker detection for both cancer and advanced adenomas, plus a simplified at-home collection process, positions it as a potentially important addition to Labcorp’s colorectal screening...
3 Mid-Cap Stocks Walking a Fine Line
Many investors pay attention to mid-cap stocks because they have established business models and expansive market opportunities. However, their paths to becoming $100 billion corporations are ripe with competition, ranging from giants with vast resources to agile upstarts eager to disrupt the status quo.
Q1 Earnings Highlights: Labcorp (NYSE:LH) Vs The Rest Of The Testing & Diagnostics Services Stocks
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Labcorp (NYSE:LH) and the best and worst performers in the testing & diagnostics services industry.
Is it the Right Time to Add Labcorp Stock to Your Portfolio?
LH expands specialty testing, acquisitions and AI initiatives to drive growth, but macro pressures and currency headwinds could weigh on results.